![]() |
|
|
Vol. 56, Issue 6, 1262-1270, December 1999
Gilead Sciences, Foster City, California (P.K); and Department of
Medicine, University of Miami School of Medicine, Miami, Florida
(K.M.D.)
Incubation of CEM cells for 24 h with the guanine,
2,6-diaminopurine, and adenine nucleotide analogs of the
9-(2-phosphonylmethoxyethyl) series,
9-(2-phosphonylmethoxyethyl)guanine (PMEG),
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP), and
9-(2-phosphonylmethoxyethyl)adenine (PMEA), was found to inhibit DNA
synthesis 50% at concentrations of 1, 6, and 25 µM, respectively.
Possible reasons for the marked differences were investigated,
including cellular transport of the analogs, different efficiencies of
intracellular phosphorylation, differential effects on
2'-deoxynucleotide (dNTP) pools, and differences in the affinities of
the cellular DNA polymerases for the diphosphate derivatives of the
drugs. No significant differences in cellular uptake were found
among the analogs; however, they did differ in the efficiency of
phosphorylation, i.e., CEM cells were found to accumulate higher levels
of PMEG-diphosphate (PMEGpp) than PMEDAP-diphosphate (PMEDAPpp) or
PMEA-diphosphate (PMEApp). Treatment of cells with any of the
nucleotide analogs resulted in increased dNTP pools, with PMEG
producing the greatest increase. All three analogs had the greatest
effect on the dATP pool size, whereas the dGTP pool size was not
significantly affected. Comparison of the ratios of nucleotide analog
diphosphates to their corresponding dNTPs under conditions where DNA
synthesis is inhibited 50% suggested that cellular DNA polymerases
were approximately twice as sensitive to PMEGpp than to PMEDAPpp and
5-fold more sensitive to PMEGpp than to PMEApp. Consistent with this
hypothesis, examination of the efficiencies with which the replicative
DNA polymerases
,
, and
incorporated the analogs showed that
DNA polymerase
, the most sensitive of the DNA polymerases,
incorporated PMEGpp twice as efficiently as PMEDAPpp and 7-fold more
efficiently than PMEApp.
This article has been cited by other articles:
![]() |
S. Botros, S. William, O. Hammam, Z. Zidek, and A. Holy Activity of 9-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]Adenine against Schistosomiasis mansoni in Mice Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3853 - 3858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kamiya, A. Kubota, Y. Iwase, K. Sekiya, M. Ubasawa, and S. Yuasa Antiviral Activities of MCC-478, a Novel and Specific Inhibitor of Hepatitis B Virus Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2872 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leblond, G. Attardo, B. Hamelin, D. Y. Bouffard, N. Nguyen-Ba, and H. Gourdeau BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: A Cyclic Nucleoside Phosphonate with Antitumor Activity Mol. Cancer Ther., July 1, 2002; 1(9): 737 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Birkus, M. Hajek, P. Kramata, I. Votruba, A. Holy, and B. Otova Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases {alpha}, {delta}, and {varepsilon} Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1610 - 1613. [Abstract] [Full Text] [PDF] |
||||